Exciva raises €51.0M round

20 January 2026

To advance Alzheimer’s drug testing in patients

Investors

LeadGimv

Also participating

EQT Life SciencesFountain Healthcare PartnersLifeArc VenturesCarma FundModi VenturesAndera PartnersLBBW